GENinCode (LON:GENI) Trading Down 11.6% – Should You Sell?

Shares of GENinCode Plc (LON:GENI) fell 11.6% during mid-day trading on Thursday . The company traded as low as GBX 1.10 and last traded at GBX 1.11. 6,105,473 shares were traded during mid-day trading, a decline of 0% from the average session volume of 6,128,636 shares. The stock had previously closed at GBX 1.25.

GENinCode Stock Down 7.6%

The company has a debt-to-equity ratio of 7.17, a quick ratio of 15.89 and a current ratio of 2.80. The company has a market cap of £8.37 million, a price-to-earnings ratio of -0.49 and a beta of 0.61. The business has a 50-day simple moving average of GBX 1.13 and a 200-day simple moving average of GBX 1.57.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.